Rare diseases
Investigational molecules
Locations
Back to Italy2 684 clinical trials in Novara, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study on GEN1046 and Pembrolizumab for Patients with Advanced Endometrial Cancer
ItalyStudy on the Safety and Effectiveness of MK-1308A, Pembrolizumab, and Lenvatinib for Patients with Advanced Liver Cancer
ItalyStudy of UCART22 for Patients with Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia
ItalyStudy on the Safety and Effects of ABBV-916 and MK-6240 for Patients with Early Alzheimer's Disease
ItalyStudy on the Long-Term Safety of Ecopipam Hydrochloride Tablets for Children, Adolescents, and Adults with Tourette's Disorder
ItalyStudy on Milvexian and Drug Combination for Patients Recovering from a Heart Attack
ItalyEvaluating Once Daily Orforglipron (LY3502970) Compared to Insulin Glargine in Adults with Type 2 Diabetes and Obesity or Overweight who Have Increased Cardiovascular Risk
ItalyStudy on Volixibat for Treating Itching in Patients with Primary Biliary Cholangitis
ItalyStudy of Durvalumab and Tremelimumab for Patients with Advanced Liver Cancer
ItalyStudy on Ravulizumab for Children with Paroxysmal Nocturnal Hemoglobinuria or Atypical Hemolytic Uremic Syndrome
ItalyStudy of Regorafenib with Chemotherapy for Newly Diagnosed Patients with Metastatic Ewing Sarcoma
ItalyStudy on the Safety and Effectiveness of SerpinPC for Patients with Hemophilia B with Inhibitors
ItalyThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on hematologic malignancies and solid tumors, investigating innovative treatments for various cancer types including leukemia, breast cancer, and lung cancer.
Studies evaluating combination therapies and targeted treatments to improve patient outcomes.
Research focusing on heart failure prevention and treatment strategies, particularly exploring new drug combinations and their impact on cardiovascular outcomes.
Innovative approaches combining multiple therapeutic agents to address cardiovascular risks.
Investigations into treatments for various autoimmune disorders, including Sjögren's Syndrome and rheumatoid arthritis, with emphasis on novel therapeutic approaches.
Focus on developing targeted therapies for better disease management and patient care.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
